• news.cision.com/
  • Sanolium/
  • Sanolium announces that the condition for the early redemption of its outstanding 2019/2024 bonds has been satisfied

Sanolium announces that the condition for the early redemption of its outstanding 2019/2024 bonds has been satisfied

Report this content

On 29 February 2024, Sanolium AB (publ) (the "Company" or "Sanolium") announced its intention to redeem in full the outstanding 2019/2024 bonds with ISIN SE0012596179 (the "Redemption" and the "Existing Bonds", respectively).

The Redemption was conditional upon the Issuer's receipt of funds in connection with the issue of new floating rate senior secured bonds under a total framework of SEK 1,500 million, with a tenor of five years and an initial amount of SEK 1,000 million, as further described in the Company's press release on 29 February 2024 (the "Financing Condition" and the "New Bonds", respectively). The Financing Condition has been satisfied and the Redemption is therefore no longer conditional.

The Redemption of the Existing Bonds will occur on 26 March 2024 and the applicable record date is 19 March 2024 (the "Record Date"). Payment will be made to each person who is registered as a holder of the Bonds in the debt register maintained by Euroclear Sweden on the Record Date.

 

For further information, please contact:

Rami Avidan, CEO, Cambio
+46 070 793 483
rami.avidan@cambio.se

Johannes Fabó, CFO, Cambio
+46 730 599 368
Johannes.fabo@cambio.se

Jenny Styren, Chief Marketing & Communications Officer, Cambio
+46 703 793 483
jenny.styren@cambio.se

This information is information that Sanolium AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at [17:00] CET on 15 March 2024.

About the Company:

Sanolium AB, parent of the Cambio Group ("Cambio" or the "Company") operating entities, is an e-health company providing comprehensive IT solutions to improve healthcare and patient safety. Cambio is one of the largest suppliers in Scandinavia with more than 200,000 users across regions and municipalities, general and university hospitals, health centers and specialist units. Cambio has offices in Sweden, Denmark, United Kingdom and Sri Lanka.

 

 

 

Subscribe